Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alyostal
- Development stage
- Unknown
- Lead developer
- Stallergenes Greer
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intradermal
01
Overview
Alyostal is a biologic product consisting of standardized allergen extracts, developed by Stallergenes for allergen immunotherapy and diagnostic skin testing. It contains various allergens, such as dust mite allergens (Dermatophagoides farinae and Dermatophagoides pteronyssinus) and bee venom, and is available in different formulations like Alyostal Aqueux (aqueous solution) and Alyostal Prick (for skin prick tests). The product is used for both the diagnosis and treatment of IgE-mediated allergic conditions. Administration is through subcutaneous immunotherapy to desensitize patients or via skin prick testing to identify specific allergies based on skin reactivity.
- Brand names
- AlyostalTrimedalAlyostal AqueuxAlyostal Prick
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on Alyostal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alyostal.